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SUMMARY 
The gene (pail) encoding human plasminogen activator inhibitor, PAI- was cloned from a IEMBL3 
genomic library and was found to span approx. 12 kb and to contain eight introns. Primer extension and Sl 
nuclease analyses both showed the transcription start point to be located 142 nt upstream from the start codon. 
The 5’-flanking region was sequenced and found to contain a TATA box, but no CAAT sequence. When a 
fragment containing 730 nt of 5’ -untranslated region was placed upstream from a promoterless cut gene, it was 
shown to function as a promoter when transfected into COS cells. Northern-blot analysis was consistent with 
low level expression of the endogenous pail gene in COS cells. When the pail gene structure was compared 
to those of other members of the serine-protease-inhibitor encoding gene family, little conservation of intron 
positions was observed. 
INTRODUCTION 
Plasminogen activators are serine proteases which 
are able to convert the inactive plasminogen into the 
active protease plasmin. Plasminogen activation is 
involved in many biological processes such as 
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Institute, University ofMichigan, 1150 West Medical Center Dr., 
Ann Arbor, MI 48109-0650 (U.S.A.) Tel. (313)747-4808; 
Fax (313)936-9353. 
Abbreviations: aa, amino acid(s); AMV, avian myeloblastosis 
virus; bp, base pair(s); cat, gene encoding Cm acetyltransferase; 
cDNA, DNA complementary to RNA; cpm, counts/mitt; Cm, 
chloramphenicol; dNTP, deoxyribonucleoside triphosphate; 
tumorigenesis, embryogenesis, and tissue repair. 
However, it has been most completely studied for its 
role as the central step in the activation of the 
fibrinolytic system (Erickson et al., 1985). 
The major form of plasminogen activator inhibitor 
found in human plasma is PAI- (for review see 
ECGF, endothelial cell growth factor; HUVEC, human umbilical 
vein endothelial cell; IL-l, interleukin-1; kb, kilobase or 
1000 bp; nt, nucleotide(s); oligo, oligodeoxyribonucleotide; 
PAI-1, plasminogen activator inhibitor-l; pail, gene (DNA) 
encoding PAI-1; PCR, polymerase chain reaction; RSV, Rous 
sarcoma virus; serpin, serine protease inhibitor; SSC, 0.15 M 
NaCl/O.OlS M Na, . citrate pH 7.6; TGFj, transforming growth 
factor B; TNFa, tumor necrosis factor a; tsp, transcription start 
point(s). 
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Loskutoff et al., 1989). PAI- is also found in 
platelets, endothelial cells, hepatoma cells, fibro- 
sarcoma cells, mesothe~~ cells, and recently as a 
major component of the extracellular matrix. 
Vascular endothehal cells may represent the major 
site of synthesis for plasma PAI-1 (Loskutoff et al., 
1989). 
Severalgroups have cloned full-length pail cDNA 
(Ginsburg et al., 1986, Ny et al., 1986, Parmekoek 
et al., 1986, Andreasen et al., 1986). In human cells 
PAI- mRNA occurs in two sizes, 2.3 kb and 3 kb, 
which differ only in the length of their 3’“untrans- 
lated regions. Both mRNAs encode a 42-45-kDa 
polypeptide which displays sequence similarity to 
other members of the serpin gene family. The human 
pail gene has been mapped to chromosome 7 
(Ginsburg et al., 1986; Klinger et al., 1987). 
The regulation of pail gene expression is complex. 
In HUVECs, PAI- activity is induced by sub- 
stances such as thrombin, endotoxin, IL-l, TNFcl 
and TGFfl, and decreased by protein C and heparin 
with ECGF. Expression of pail has also been shown 
to be induced by glucocorticoids in hepatoma and 
~bros~coma cells (Loskutoff et al., 1989). 
We have used a PAI-1 cDNA probe to screen a 
human genomic library and have isolated overlap- 
ping clones which contain the pail gene. The exon 
structure and the rsp were determined. A fragment 
containing 730 bp of 5’-flanking sequence was found 
to act as a promoter when transfected into COS 
cells. The gene structure of PAI- was compared to 
that of other serpins. 
MATERIALS AND METHODS 
(a) Genomic cloning 
Approximately 2 x IO6 recombinant clones from 
an amplified partial Sau3A human genomic library 
(obtained from P. Venta, University of Michigan) 
constructed in the 2EMBL3 vector (Frischaufet al., 
1983) were screened by hybridization to the 32P- 
labeled 2-kb EcoRI insert fragment of cDNA clone 
PAIB6 (Ginsburg et al., 1986). Four overlapping 
clones containing pail gene sequences were identi- 
fied. Restriction fragments were subcloned into 
pGEMblue (Promega) and a detailed restriction 
map was constructed by standard methods (Maniatis 
et al., 1982). Probes were radiolabeled using the 
random hexamer method (Feinberg and Vogelstein, 
1983). Sequencing was by the dideoxy method 
(Sanger et al., 1977) using Sequenase (U.S. 
Biochemical Corporation). Oligo sequencing primers 
were synthesized based on the PAI- cDNA se- 
quence designed to sequence across the splice 
junctions as reported by Loskutoff et al. (1987). 
(b) Polymerase chain reaction 
Reactions were performed as previously described 
(Ginsburg et al., 1989). Either 100 ng of the 
IEMBL3 phage clone 4A DNA, 100 ng of control 
plasmid DNA, or 100 ng of normal genomic DNA 
were added to each reaction mix in addition to 0.02 
A 260 of each 30-mer oligo primer. Tuq polymerase 
(Cetus) was used according to the manufacturer’s 
~s~~tions. PCR conditions were 94°C for 1 min, 
15 s, followed by 72°C for 4 min repeated for 30 
cycles. The oligos used for intron 3 were the follow- 
ing. (3A) GATGAGATCAGCACCACAGACGC- 
GATCTTC, PAI-1 cDNA positions 334-363 
(Ginsb~g et al., 1986), and (3B) 5’-GCACAG- 
AGACAGTGCTGCCGTCTGA~GT, comple- 
mentary to positions 638 through 667. Oligos for 
intron 4 were the following. (4A) 5’-ACTCCC’ITC- 
CCCGACTCCAGCACCCACCGC, located from 
nt 598-627; and (4B) 5’-GGTGTCCCCGTG- 
GTAGGGCAG~CCAGGAT, complements to 
nt 736-765. 
(c) Computer analysis 
A~~rnent of serpin aa sequences was performed 
using the Needleman-Wunsch (1970) algorithm 
through the Sequence Analysis Software Package 
(Genetics Computer Group at the University of 
Wisconsin). 
RESULTS AND DISCUSSION 
(a) Gene cloning 
A human genomic library in aEMBL3 was 
screened with a full-length human cDNA clone. 
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MCTTCAC 1 GTAGGA........TITCCA~G~~AC 
MG ATT CAT C 1 GTGACC........T~GTCCCGGTGCAG 
Lys Ilc Asp Asp 
86 89 90 91 
CAC ACA MA C I GTGAGC..,.....TTGATTITCCCATAG 
Him Thr Lys cly 
166 167 168 169 
7-X MC TAT A 1 GTAAGT........TTGTCGTC’l-,‘CACAG 
Phe As” Tyr Thr 
231 2,2 2,, 2,4 
CTG CCC AA I GTMGC........TGCTC~AT~GCAG 
Leu Pro Lys 
296 299 ,cJo 
ACT CTT TCA C 1 GTAAGA........CCACATCGTTTCAG 
Ser Leu Ser Asp 
311 ,,2 ,,, ,,a 
TCA TCC ACA C I CTGAGT........TCCCIT~CITGCAC 
Ser Ser Thr Ala 
360 361 362 ,6, 
MC CCC ACA C ( GTGAGC.. . . . . ..TTCTTCCACCCITAG 
Asn Pro Thr Cly 
388 ,69 390 ,91 











TTTGATAACT CCACAGTGAC CTGGTTCGCC MAGGMMG 
TTTTTTCTCC AAGCTGAACA TAGGGGTCC TAGGCTTTTG 
AGTCMCCTG GCAGGACATC CGGGAGAGAC AGACACAGGC 
GAGGTTCTCA GGCCMGGCT ATTGGGGTTT GCTCAATTGT 
GTACACACAC AGAGCAGCAC ACACACACAC AC- 
GAGGTGTCGA GGGGGACCCG CTGGCTGTTC AGACGGACTC 
GGGCTGGMC ATGAGTTCAT CTATTTCCTG CCCACATCTG 
0 
CCACAGAGGA GCACAGCTGT GTTTGGCTGC AGGGCCMGA 
ACGCCCCCCT CCAGCAGCTG MTTCCTGCA GCTCAGCAGC 
CCGCCAATCG CAAGGCACCT CTGAGMCTT CAGIGATG 
Met 
) AC AAG GGC 
tys c1y 
92 93 
’ CT 8:: E 
215 236 
1 G ?-l-C TCC 
Phe s*r 
301 ,02 
’ cT 2 :T: 
,64 365 












Fig. 1. Structure and sequence of pail gene. (A) Gene structure. Restriction sites are marked above the map. E, EcoRI; H, HindHI; 
N, NcoI; S, SalI. Exons are numbered from below. Phage clone 4A obtained from a IEMBL3 genomic library encompasses the entire 
region shown in detail, as well as greater than 8 kb of upstream sequence. The two flanking SalI sites have been contributed by the 
phage. (B) PAI- intron/exon boundaries. Sequences of the intron/exon splice junctions are shown. Appropriate aa are listed below the 
codons. The mRNA splicing consensus sequences (Padgett et al., 1986) are shown in the bottom line for comparison. (C) Sequence of 
the pail promoter region. The TATA box is underlined and in bold type. The major fsp is the adenine residue located under the 
arrowhead. The possible Z-DNA forming region is also underlined. Met denotes the initiation methionine. The short vertical line 
indicates the location of intron 1. 
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subjected to restriction endonuclease mapping. 
Clone 4A was found to contain an insert of greater 
than 19 kb and was studied in further detail. Exons 
were located by restriction enzyme mapping and 
Southern-blot analysis. All of the clones isolated 
stop at the Sau3a site approx. 650 bp 5’ of the distal 
polyadenylation signal used for the 3 kb PAI- 
mRNA species. Clone 4A extends approx. 8 kb 
upstream from the first exon. The structure of clone 
4A was confirmed by comparison with Southern 
blots of human DNA (not shown). 
(b) Gene structure 
The human pail gene spans approx. 12 kb and 
contains eight introns (Fig. la). The locations of 
exon 4 was deduced using PCR to determine the 
sizes of introns C and D. All exons were sequenced 
in their entirety and the sequence was found to be 
identical to that of our previously reported cDNA 
sequence (Ginsburg et al., 1986). The intron/exon 
boundary sequences are shown in Fig. lb and were 
found to conform to the known consensus sequences 
(Padgett et al., 1986). Sequencing differences were 
seen in the splice acceptor sequences of introns A, D, 
E and F when compared to Loskutoff et al. (1987), 
though our sequence agrees completely with that of 
Bosma et al. (1988) and Strandberg et al. (1988). 
The 300-bp EcoRI fragment located in intron 3 
contains an Mu repeat and is not present in the gene 
structure of Loskutoff et al. (1987). 
An optimal alignment of the PAI- protein se- 
quence with that of other members of the serpin 
family was determined, and the relative locations of 
the introns were compared. Our results are consistent 
with those of Strandberg et al. (1988). As previously 
noted, conservation of intron positions among ser- 
pins correlates poorly with aa sequence similarity 
(Bao et al., 1987). The degree of aa sequence simi- 
larity has frequently been used to estimate evolu- 
tionary relatedness among proteins. We hypothesize 
that the presence or absence of introns should be 
subject to weaker selective pressures than aa se- 
quence, and thus may provide a more reliable mea- 
sure of evolutionary relatedness within the serpin 
family than aa sequence. A similar hypothesis was 
suggested by Ragg and Preibisch (1988) in their 
analysis of the serpin hLS2. 
The tsp for pail transcription was determined by 
primer extension and Sl nuclease analysis (Fig. 2). 
With both methods, the tsp was shown to be 142 bp 
5’ of the start codon (Figs. lc and 2). 432 bp of 
upstream promoter sequence was determined on 
SC?qUenCX: 3’ CCGGGTGTCTCCTCGTGTCGACACAAACCGA 5’ 
5’ GGCCCACAGAGGAGCACAGCTGTGTTTGGCT 3’ 
. 
PRIMER EXTENSION Sl NUCLEASE 
ACGT ACGT 
Fig. 2. Mapping of the tsp. Both primer extension and Sl 
nuclease reactions are shown. The sequence seen in the gels is 
that of the antisense strand. The sequences of both sense and 
antisense strands are shown above. Arrowheads indicate the 
transcription start site. A primary culture of HUVECS (gift of 
S. Weiss, University of Michigan) was grown and passaged as 
previously described (Konkle and Ginsburg, 1988). Isolation of 
total RNA (Strohman et al., 1977) and oligo(dT) cellulose (Col- 
laborative Research) chromatography (Aviv and Leder, 1972) 
were preformed as described. Sl analysis was performed as 
described by Ausubel et al. (1987) with minor modifications. A 
17-mer oligo (Pl) of sequence 5’-TGGCGGTTCGTCCTGCT 
and complementary to nt + 98 to + 115 of pail (Fig. lc) was 
used as primer. 6 x 10 _ 4 A,,, units of Pl were end-labeled with 
T4 polynucleotide kinase (New England Biolabs) and 100 &i of 
[Y-~~P]ATP (5000 Ci/mmol) (Amersham). 2.4 x lo5 cpm of gel- 
purified probe was added to 20 ng of total HUVEC RNA and 
hybridized overnight at 30°C. Half of the final sample was 
loaded onto a denaturing 8% polyacrylamide gel. The size 
marker for both S 1 nuclease and primer extension analyses was 
a sequencing reaction using the same end-labeled oligo Pl as 
primer with plasmid subclone S4 as template. For the primer 
extension reaction, Pl was end-labeled as above and then puri- 
fied on a 15 % polyacrylamide gel. 1.3 x 10’ cpm oflabeled probe 
(with a spec. act. of approx. 1.5 x lo6 cpm/mg DNA) was added 
to 2 mg of poly(A)+mRNA, heated at 90°C for 2 min, and then 
incubated for 1.5 h at 52°C in 50mM Tris pH S/SO mM 
KC1/5 mM MgCl,/lO mM dithiothreitol. After cooling slowly to 
37OC.4 units ofAMV reverse transcriptase (Seikagaku America, 
Inc.) were added and the reaction made 100 mM with respect to 
dTTP, dCfP, dGTP, and dATP. This mixture was then incubated 
at 37°C for 35 min. An equal volume offormamide loading buffer 
was then added to the tube, and the products were analyzed by 
electrophoresis on an 8% polyacrylamide sequencing gel. 
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both strands (Fig. lc) and consensus promoter ele- 
ments were noted as previously observed (Bosma 
et al., 1988 and Fig. lc). 
The location of the pail tsp is consistent with the 
observation that A residues are the most common 
nt used at the zsp (Salditt-Georgieff et al., 1980) and 
that CA is the most common motif at the cap site 
(Bucher and Trifonov, 1986). Our results agree with 
those found by Riccio et al. (1988) in their S 1 
analyses on a variety of cell types and Strandberg 
et al. (1988) in Sl analysis of human placenta. 
Bosma et al. (1988) and Van Zonnefeld et al. (1988) 
have localized the start 3 nt upstream from this site 
at an A residue which follows a G. In both of our 
experiments secondary bands became visible upon 
longer exposure, one of which was located at this 
second A residue, possibly representing a weak 
alternative tsp. 
(c) Promoter function 
To test whether the region upstream from the pail 
gene could function as a eukaryotic promoter, an 
800-bp NcoI-EcoRI fragment which contained ap- 
prox. 730 bp of 5’flanking region was inserted 5’ of 
the bacterial cat gene in both orientations in the 
vector pUMSV0. Plasmid pRSVCAT was used as 
a positive control. The 800-bp EcoRI-NcoI pail frag- 
ment was shown to function as a promoter in COS 
cells only in the correct orientation (Fig. 3). This 
segment is a much weaker promoter in COS cells 
than the strong viral promoter of RSV. 
Northern-blot analysis of HUVEC and COS total 
RNA probed with radiolabeled pail cDNA revealed 
that COS cells contain the PAI- message (Fig. 4). 
The relative amount of PAI- in COS cells appears 
to be substantially lower than that in HUVECs. 
Since COS cells are derived from the kidney epi- 
thelium of the African green monkey (Jensen et al., 
1964), these results are consistent with the previous 
detection of PAI- antigen in BSC-1, another 
monkey kidney epithelial cell line (Thalacker and 
Nilsen-Hamilton, 1987). 
In human cells, PAI- mRNA is of two sizes, a 
smaller 2.3-kb message and a larger 3-kb message. 
This size difference has been postulated to be due to 
either differential splicing or to the use of different 
polyadenylation sites. The absence of an intron at 
A -B C D E F G H 
Fig. 3. CAT assays of transfected COS cell extracts. Lanes: 
A, pSV0; B, pUMSV0 (CAT activity normalized for trans- 
fection efficiency; 0.81 and 1 respectively); C and D, duplicate 
transfections of pail promoter fragment in reverse orientation 
(CAT activity: 1.11 k 0.5); E and F, duplicate transfections of 
pail promoter fragment in forward orientation (CAT activity: 
18 f 7); G and H, duplicate transfections of pRSVCAT (CAT 
activity: at least 2890 f 686). COS cells were grown and pas- 
saged as previously described (Ginsburg et al., 1989). An 800-bp 
NcoI-EcoRI fragment containing 730 bp of sequence 5’ to the rsp 
was cloned in both orientations into the vector pUMSV0 (Salier 
and Kurachi, 1989) which contains the bacterial cat gene. Plas- 
mid pRSVCAT (Gorman et al., 1982) was transfected as a posi- 
tive control. The transfection protocol used was that of Chen and 
Okayama (1987). Of the test plasmid, 10 pg along with 1 pg of 
pRSVGH (Selden et al., 1986) as a transfection control, were 
added to loo-mm dishes which had been seeded 24 h earlier with 
1 x lo5 COS cells. The amount of growth hormone present 72 h 
after transfection was assayed using a commercial kit (Nichols 
Diagnostics) and following the manufacturer’s instructions. CAT 
assays were performed according to standard procedures 
(Gorman et al., 1982) with a reaction time of 1 h for the quantita- 
tive comparisons. The amount of protein present in each cell 
extract was measured using a standard Bradford assay (Bio-Rad) 
according to the manufacturer’s instructions. Amounts of extract 
normalized for a protein content of 275 pg to be used in each 
CAT assay reaction except for pRSVCAT in which */IO of this 
amount was used. Except for pSV0 and pUMSV0, all trans- 
fections were done in duplicate. Differences in transfection et& 
ciencies were corrected by normalizing the CAT assay values 
relative to the growth-hormone assay, with pUMSV0 set as 1.0, 
and the mean and standard deviation for each were calculated. 
The reaction shown here was derived from the same cell extracts, 
and the conditions were identical to those described above except 
for a reaction time of 2 h, and dilution of pRSVCAT extract to 
1: 8 instead of 1: 10. The value for pRSVCAT is out of the linear 




Fig. 4. Northern-blot analysis of total HUVEC and COS cell 
RNA was performed as described (Ginsburg et al., 1986). The 
final two washes were in 0.1 x SSC and 0.1% SDS at 68°C for 
30 min each. Film was developed after a 16 h exposure at -80°C 
with an intensifying screen. The probe used was the same as that 
used to screen the genomic library. Equal amounts (10 pg) of 
total RNA was loaded on each lane. The quantity of RNA 
present in each lane appeared equal by the comparison of 18s 
and 28s rRNA bands visualized by ethidium bromide staining 
(not shown). The locations of the 28s and 18s rRNA bands are 
indicated. 
the end of the 2.3-kb message confirms that this size 
difference is due to alternative polyadenylation 
(Loskutoff et al., 1987; Bosma et al., 1988; Strand- 
berg et al., 1988). It is interesting to note that both 
messages are present in COS cells, as in human cells 
(Fig. 4). When PAI- mRNA has been examined in 
other species only the larger 3-kb mRNA species is 
seen [bovine (Sawdey et al., 1986), rat (Zeheb and 
Gelehrter, 1988), and porcine, (M.F. and D.G., 
unpublished data)]. Processing at the proximal 
polyadenylation signal producing the 2.3-kb mRNA 
species removes an A + T-rich palindromic sequence 
which has been hypothesized to play a role in 
regulating pail gene expression (Ginsburg et al., 
1986). The significance of the shorter message 
observed only in primate species remains to be 
determined. 
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